Growth Metrics

Gyre Therapeutics (GYRE) Other Non-Current Assets (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Other Non-Current Assets for 15 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 17.76% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, down 17.76% year-over-year, with the annual reading at $2.5 million for FY2025, 17.76% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $2.5 million at Gyre Therapeutics, down from $5.3 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $5.6 million in Q1 2025, with the low at $168000.0 in Q2 2022.
  • Average Other Non-Current Assets over 5 years is $1.8 million, with a median of $932000.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Assets tumbled 85.63% in 2022, then soared 1546.43% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $472000.0 in 2021, then skyrocketed by 619.07% to $3.4 million in 2022, then crashed by 70.68% to $995000.0 in 2023, then skyrocketed by 204.52% to $3.0 million in 2024, then decreased by 17.76% to $2.5 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $2.5 million, $5.3 million, and $5.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.